164 related articles for article (PubMed ID: 28010941)
1. [French translation of the clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher (eGFR<45mL/min/1.73 m
Jourde-Chiche N; Guerrot D; Chauveau D; Boffa JJ
Nephrol Ther; 2017 May; 13(3):138-145. PubMed ID: 28010941
[No Abstract] [Full Text] [Related]
2. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
[TBL] [Abstract][Full Text] [Related]
3. Updated management of chronic kidney disease in patients with diabetes.
Hass VM
JAAPA; 2014 Jun; 27(6):17-22. PubMed ID: 24819952
[TBL] [Abstract][Full Text] [Related]
4. Progression of stages 3b-5 chronic kidney disease--preliminary results of Taiwan national pre-ESRD disease management program in Southern Taiwan.
Lin CM; Yang MC; Hwang SJ; Sung JM
J Formos Med Assoc; 2013 Dec; 112(12):773-82. PubMed ID: 24309170
[TBL] [Abstract][Full Text] [Related]
5. The KDIGO guidelines on diabetes and chronic kidney disease, 2020: An appraisal.
Kalra S
Diabet Med; 2021 Jul; 38(7):e14561. PubMed ID: 33772854
[No Abstract] [Full Text] [Related]
6. Some specificities in the management of hyperglycemia in patients with diabetic kidney disease.
Dragović T; Marinković D; Kiković S; Pejović J; Hajduković Z
Vojnosanit Pregl; 2016 Sep; 73(9):857-63. PubMed ID: 29320619
[No Abstract] [Full Text] [Related]
7. [Novel diagnostic and therapeutic procedures in diabetic nephropathy].
Pont'uch P
Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S57-62. PubMed ID: 27124974
[TBL] [Abstract][Full Text] [Related]
8. Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations?
Muller C; Dimitrov Y; Imhoff O; Richter S; Ott J; Krummel T; Bazin-Kara D; Chantrel F; Hannedouche T; ;
J Diabetes Complications; 2016; 30(4):675-80. PubMed ID: 26900098
[TBL] [Abstract][Full Text] [Related]
9. Metformin associated lactic acidosis (MALA): clinical profiling and management.
Moioli A; Maresca B; Manzione A; Napoletano AM; Coclite D; Pirozzi N; Punzo G; Menè P
J Nephrol; 2016 Dec; 29(6):783-789. PubMed ID: 26800971
[TBL] [Abstract][Full Text] [Related]
10. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.
National Kidney Foundation
Am J Kidney Dis; 2012 Nov; 60(5):850-86. PubMed ID: 23067652
[TBL] [Abstract][Full Text] [Related]
11. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
Zhang Y; Ruan Y; Zhang P; Wang L
J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
[TBL] [Abstract][Full Text] [Related]
12. Management of diabetes in patients with chronic kidney disease.
Ahmed Z; Simon B; Choudhury D
Postgrad Med; 2009 May; 121(3):52-60. PubMed ID: 19491540
[TBL] [Abstract][Full Text] [Related]
13. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
[TBL] [Abstract][Full Text] [Related]
14. [Prepare: cross-sectional study on management of chronic kidney disease by nephrologists before dialysis in France].
Daugas E; Dussol B; Henri P; Joly D; Juillard L; Michaut P; Mourad G; Stroumza P; Touam M
Nephrol Ther; 2012 Nov; 8(6):439-50. PubMed ID: 23022292
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of diabetic kidney disease.
Gosmanov AR; Wall BM; Gosmanova EO
Am J Med Sci; 2014 May; 347(5):406-13. PubMed ID: 24553399
[TBL] [Abstract][Full Text] [Related]
17. Effects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetes.
Wu HY; Fukuma S; Shimizu S; Norton EC; Tu YK; Hung KY; Chen MR; Chien KL; Fukuhara S
Am J Kidney Dis; 2017 Nov; 70(5):666-674. PubMed ID: 28764919
[TBL] [Abstract][Full Text] [Related]
18. Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine.
Tuot DS; Lin F; Shlipak MG; Grubbs V; Hsu CY; Yee J; Shahinian V; Saran R; Saydah S; Williams DE; Powe NR;
Diabetes Care; 2015 Nov; 38(11):2059-67. PubMed ID: 26307607
[TBL] [Abstract][Full Text] [Related]
19. [Chronic Kidney Disease - Update 2018].
Ketteler M; Wanner C
Dtsch Med Wochenschr; 2018 Feb; 143(3):169-173. PubMed ID: 29409087
[TBL] [Abstract][Full Text] [Related]
20. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group.
Farrington K; Covic A; Nistor I; Aucella F; Clyne N; De Vos L; Findlay A; Fouque D; Grodzicki T; Iyasere O; Jager KJ; Joosten H; Macias JF; Mooney A; Nagler E; Nitsch D; Taal M; Tattersall J; Stryckers M; van Asselt D; Van den Noortgate N; van der Veer S; van Biesen W
Nephrol Dial Transplant; 2017 Jan; 32(1):9-16. PubMed ID: 28391313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
